Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9052)	6/3/1998 6:59:00 PM
From: Colby	Read Replies (1) \| Respond to of 23519

Vlad, as I understand (which is somewhat minimally) market makers do exactly that, make markets. I read an article about MM's. Apparently, on huge days, only about 45% of the volume is actually investor generated. The rest is MM's trading between themselves or placing themselves between buyers and sellers. I also understand a lot of their trades don't get seen. This being the case (if it is the case) isn't pretty hard to interpret a MM's intentions. Couldn't they just be making $ on the spreads like every other market maker? I ask because I have seen many people get falsly excited about a big house accumulating shares in hopes of an upgrade only to see nothing happen. Just curious, Colby

To: VLAD who wrote (9052)	6/3/1998 7:54:00 PM
From: RT	Read Replies (1) \| Respond to of 23519

To ALL, Ladies and gentleman, it is not the product that is a failure, it is the management of this company. Management has always been the sticking point with Vivus. Leland does not know which end is up. He is consistently behind the power curve. He cannot see danger. He's an accident looking for a happening. Leland though he saw light at the end of the tunnel. What he really saw was the light of a freight train barreling his way at 100MPH. After reading the profile of the VA patients used in this study it's no wonder the product didn't work. Even a lay person can read through such BS. Surely, Vivus's management should have been ready to discredit the review. Instead they put their heads up their fanny's and mumbled, No Comment. If this stock went to 100 tomorrow, I would still want this impotent management team removed.. Analysts have not forgotten the screw job they received from Vivus last year when they failed to mention the upcoming shortfall and we will be stigmatized for years to come. RT